7:30am
Registration/Coffee/Visit Exhibits
8:00am
Breakfast Served
8:00-9:00
PRODUCT THEATRE I - Non-CME
Breaking the Cycle of Recurrent Pericarditis: A Targeted Approach for Pain Relief, Inflammation Resolution, and Flare Prevention
Speaker: Rigved Tadwalkar, MD
Supported by: Kiniksa Pharmaceuticals
9:10-9:15
Welcome and Introduction to the Symposium: Heart Failure in 2024
Barry Greenberg, MD, FACC
SESSION I - Modifying Lifestyle and Treating Risk Factors to Prevent CV Disease
Pam Taub, MD, FACC (Moderator)
9:15-9:35
FEATURED LECTURE I
The Cardiometabolic Syndrome: A New Framework for Understanding Heart Failure
Pam Taub, MD, FACC
9:35-9:50
Treating Hypertension: Goals and New Strategies for Achieving Them
Joachim Ix, MD
9:50-10:05
The Role of GLP1 Agonists in Cardiovascular Disease and Heart Failure
Yehuda Handelsman, MD
10:05-10:20
New Options for Treating Dyslipidemia
Harpreet Bhatia, MD, FACC
10:20-10:30
Risk Management: A Patient’s Perspective
Rhonda Monroe
10:30-10:50
Panel Discussion on Managing Cardiometabolic Risk
Pam Taub, MD, FACC (Moderator)
Drs. Handelsman, Ix, Bhatia and Jade Kozuch, PharmD, and Rhonda Monroe - Patient Advocate
(Panelists)
10:50-11:20
Coffee Break/Visit Exhibits
Session II - Advances in Patient Management
Barry Greenberg, MD, FACC (Moderator)
11:20-11:40
FEATURED LECTURE II
Advances in Understanding and Treating Patients with HFpEF
Uri Elkayam, MD, FACC
11:40-11:55
Using Artificial Intelligence and Machine Learning To Diagnose and Predict Outcomes in Heart Failure – What Does the Future Hold?
David Krummen, MD, FACC
11:55-12:10pm
Pulmonary Arterial Hypertension (PAH)
Jenny Yang, MD
12:10-12:25
Advances in Remote Monitoring
Hao (Howie) Tran, MD, FACC
12:25-12:40
Panel Discussion/Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs. Elkayam, Krummen, Yang, Tran
(Discussants)
12:50-1:50
PRODUCT THEATRE II - Lunch Session - Non-CME
Symptomatic Obstructive Hypertrophic Cardiomyopathy: A review of the phase 3 data and ongoing long-term extension trials with the first and only approved cardiac myosin inhibitor for adults with oHCM
Speaker: Jorge Silva Enciso, MD
Supported by: Bristol Myers Squibb
1:50-2:10
Visit Exhibits
Session III - Cardiomyopathy: Understanding Causes and Novel Therapies
Marcus Anthony (Tony) Urey, MD (Moderator)
2:10-2:30
FEATURED LECTURE III
Diagnosing and Treating Amyloidosis
Marcus Anthony (Tony) Urey, MD
2:30-2:45
Hypertrophic Cardiomyopathy
Jorge Silva, MD
2:45-3:00
Genetic Testing: When To Order It and What To Do With the Results
Kimberly Hong, MD
3:00-3:20
FEATURED LECTURE IV
Genetic Causes of Cardiomyopathy
Eric Adler, MD, FACC
3:20-3:35
Gene Therapy for Cardiac Disease
Barry Greenberg, MD, FACC
3:35-3:50
Recognizing and Treating Uncommon Causes of Cardiomyopathy
Ben Cruz, MD
3:50-4:05
A Patient’s Perspective
Lisa Salberg, Patient Advocate
Founder and CEO Hypertrophic Cardiomyopathy Association
4:05-4:40
Case Presentation / Q & A
Marcus Anthony (Tony) Urey (Presenter)
Drs. Silva, Hong, Adler, Greenberg, Cruz, Lisa Salberg - Patient Advocate (Panelists)
4:40
Adjourn for the Day
7:30-8:00am
Registration Open
8:00-9:00
PRODUCT THEATRE III - Non-CME
Breakfast Session
Harnessing SGLT Inhibition in the Treatment of HF
Speakers: Barry Greenberg, MD and Matthew Budoff, MD
Supported by: Lexicon
9:15-9:40
Founders Lecture: The Future of Heart Failure Care
Barry Greenberg, MD, FACC
Session IV - Management of Patients with Heart Failure with Reduced Ejection Fraction
Barry Greenberg, MD, FACC (Moderator)
9:40-9:55
SGLT2 Inhibitors: A Therapy for All Patients With Heart Failure?
Clyde Yancy, MD
9:55-10:15
Guideline Directed Medical Therapy for Patients with HFrEF
Gregg Fonarow, MD, FACC
10:15-10:30
Providing Care for All
Luis Castellanos, MD
10:30-10:45
Diagnosing and Treating Iron Deficiency in Patients with Heart Failure
Hilary Shapiro, MD, FACC
10:45-11:00
Other Therapies (Finerenone, Hydralazine/Isosorbide, Ivabradine, Fish Oil)
Quan Bui, MD
11:00-11:10
Living with Heart Failure: What Do Patients Want? – A Patient’s Perspective
Rhonda Monroe
11:10-11:30
Panel Discussion - Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs. Fonarow, Yancy, Castellanos, Shapiro, Bui and Trina Huynh Pharm D, Julia McCain PA, Rhonda Monroe (Panelists)
11:30-11:45
Visit Exhibits
11:45-12:45
PRODUCT THEATRE IV - Lunch Session - Non-CME
A Treatment Option for Patients with Heart Failure
Speakers: Vladimir Yurukov, PharmD, BCPS, APh and Paul Tomasic, MD, MS, FACP, FACE
Supported by: AstraZeneca
12:45-1:00
Visit Exhibits
1:00-1:25
10th Annual Stanley Lloyd, MD Lecture
Heart Failure and Pregnancy
Uri Elkayam, MD, FACC
Special Session: Advances in Treating Patients with Cardiogenic Shock
Hao (Howie) Tran, MD, FACC (Moderator)
1:25-1:40
Cardiogenic Shock: Importance of Early Recognition
Kimberly Hong, MD
1:40-1:55
Virtues of a Cardogenic Shock Program
Chris Barnett, MD, FACC
1:55-2:10
Management of Cardiogenic Shock
Hao (Howie) Tran, MD, FACC
2:10-2:25
Recognizing CAD in Patients with Heart Failure
Greg Fonarow, MD, FACC
2:25-2:40
Impact of Revascularization on HF Symptoms: Insights from Restore-EF and Protect III
Chris Barnett, MD, FACC
2:40-3:00
Coffee Break/Visit Exhibits
Session V - Novel and Advanced Therapies for Heart Failure
Barry Greenberg, MD, FACC (Moderator)
3:00-3:20
FEATURED LECTURE V
Heart Pumps Now and For the Future
Mandeep Mehra, MD
3:20-3:40
FEATURED LECTURE VI
Advances in Heart Transplantation - What Does the Future Hold?
Victor Pretorius, MD
3:40-4:00
Novel Interventions for Treating the Failing Heart
Ryan Reeves, MD
4:00-4:20
Panel Discussion / Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs Mehra, Pretorius and Reeves (Panelists)
4:20
Adjourn Until 31st Annual San Diego Heart Failure Symposium in July 2025